PCV19 COMPARATIVE RISK OF HEART FAILURE HOSPITALIZATIONS ASSOCIATED WITH DAPAGLIFLOZIN VS. EMPAGLIFLOZIN IN TYPE 2 DIABETES PATIENTS: A POPULATION-BASED COHORT STUDY
Abstract
Authors
S.C. Shao K.C. Chang Y.H. Chen Y.Y. Chan H.Y. Chen E.C.C. Lai